Published online before print July 31, 2003, doi: 10.1161/01.RES.0000089460.12061.E1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 17, 2003
Revised on July 22, 2003
Accepted on July 23, 2003
Fibroblast Growth Factor Receptor-1 Is Essential for In Vitro Cardiomyocyte Development
Patrizia Dell'Era ;
From the Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology (P.D.E., R.R., L.C., S.N., M.P.) and the Department of Experimental and Applied Medicine (M.M.), University of Brescia, Brescia, Italy.
* To whom correspondence should be addressed. E-mail: presta{at}med.unibs.it.
Fibroblast growth factor (FGF)/FGF receptor (FGFR) signaling plays a crucial role in mesoderm formation and patterning. Heartless mutant studies in Drosophila suggest that FGFR1, among the different FGFRs, may play a role in cardiogenesis. However, fgfr1-/- mice die during gastrulation before heart formation. To establish the contribution of FGFR1 in cardiac development, we investigated the capacity of murine fgfr1+/- and fgfr1-/- embryonic stem (ES) cells to differentiate to cardiomyocytes in vitro. Clusters of pulsating cardiomyocytes were observed in >90% of 3-dimensional embryoid bodies (EBs) originated from fgfr1+/- ES cells at day 9 to 10 of differentiation. In contrast, 10% or less of fgfr1-/- EBs showed beating foci at day 16. Accordingly, fgfr1-/- EBs were characterized by impaired expression of early cardiac transcription factors Nkx2.5 and d-Hand and of late structural cardiac genes myosin heavy chain (MHC)-
, MHC-
, and ventricular myosin light chain. Homozygous fgfr1 mutation resulted also in alterations of the expression of mesoderm-related early genes, including nodal, BMP2, BMP4, T(bra), and sonic hedgehog. Nevertheless, fgfr1+/- and fgfr1-/- EBs similarly express cardiogenic precursor, endothelial, hematopoietic, and skeletal muscle markers, indicating that fgfr1-null mutation exerts a selective effect on cardiomyocyte development in differentiating ES cells. Accordingly, inhibitors of FGFR signaling, including the FGFR1 tyrosine kinase inhibitor SU 5402, the MEK1/2 inhibitor U0126, and the protein kinase C inhibitor GF109 all prevented cardiomyocyte differentiation in fgfr1+/- EBs without affecting the expression of the hematopoietic/endothelial marker flk-1. In conclusion, the data point to a nonredundant role for FGFR1-mediated signaling in cardiomyocyte development.
Key words: fibroblast growth factor receptor • cardiomyocytes • embryonic stem cells
This article has been cited by other articles:
 |
|
 |
|
  H. Sadek, B. Hannack, E. Choe, J. Wang, S. Latif, M. G. Garry, D. J. Garry, J. Longgood, D. E. Frantz, E. N. Olson, et al. Cardiogenic small molecules that enhance myocardial repair by stem cells PNAS, April 22, 2008; 105(16): 6063 - 6068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. U. Magnusson, A. Dimberg, S. Mellberg, A. Lukinius, and L. Claesson-Welsh FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin Blood, December 15, 2007; 110(13): 4214 - 4222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ueno, G. Weidinger, T. Osugi, A. D. Kohn, J. L. Golob, L. Pabon, H. Reinecke, R. T. Moon, and C. E. Murry From the Cover: Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells PNAS, June 5, 2007; 104(23): 9685 - 9690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Pallante, I. Duignan, D. Okin, A. Chin, M. C. Bressan, T. Mikawa, and J. M. Edelberg Bone Marrow Oct3/4+ Cells Differentiate Into Cardiac Myocytes via Age-Dependent Paracrine Mechanisms Circ. Res., January 5, 2007; 100(1): e1 - e11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Norstrom, K. Akesson, T. Hardarson, L. Hamberger, P. Bjorquist, and P. Sartipy Molecular and Pharmacological Properties of Human Embryonic Stem Cell-Derived Cardiomyocytes Experimental Biology and Medicine, December 1, 2006; 231(11): 1753 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nemir, A. Croquelois, T. Pedrazzini, and F. Radtke Induction of Cardiogenesis in Embryonic Stem Cells via Downregulation of Notch1 Signaling Circ. Res., June 23, 2006; 98(12): 1471 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Raikwar, T. Mueller, and N. Zavazava Strategies for Developing Therapeutic Application of Human Embryonic Stem Cells Physiology, February 1, 2006; 21(1): 19 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yuan, I. Kurek, J. English, and R. Keenan Laboratory-Directed Protein Evolution Microbiol. Mol. Biol. Rev., September 1, 2005; 69(3): 373 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes & Dev., May 15, 2005; 19(10): 1129 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W.M. van Hinsbergh and T. J. Rabelink FGFR1 and the Bloodline of the Vasculature Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 883 - 886. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Nichols and T. L. Creazzo L-type Ca2+ channel function in the avian embryonic heart after cardiac neural crest ablation Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1173 - H1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rothhammer, I. Poser, F. Soncin, F. Bataille, M. Moser, and A.-K. Bosserhoff Bone Morphogenic Proteins Are Overexpressed in Malignant Melanoma and Promote Cell Invasion and Migration Cancer Res., January 15, 2005; 65(2): 448 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rudy-Reil and J. Lough Avian Precardiac Endoderm/Mesoderm Induces Cardiac Myocyte Differentiation in Murine Embryonic Stem Cells Circ. Res., June 25, 2004; 94(12): e107 - e116. [Abstract] [Full Text] [PDF]
|
|